Soliris and Cataract - a phase IV clinical study of FDA data
Summary:
Cataract is reported as a side effect among people who take Soliris (eculizumab), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Prednisone, and have Paroxysmal nocturnal haemoglobinuria.
The phase IV clinical study analyzes which people have Cataract when taking Soliris. It is created by eHealthMe based on reports of 58,774 people who have side effects when taking Soliris from the FDA, and is updated regularly.
What is Soliris?
Soliris has active ingredients of eculizumab. It is often used in paroxysmal nocturnal hemoglobinuria (pnh). eHealthMe is studying from 58,821 Soliris users. Check the latest studies of Soliris.
What is Cataract?
Cataract (clouding of the lens inside the eye) is found to be associated with 1,896 drugs and 2,131 conditions by eHealthMe. Check the latest studies of Cataract.
58,774 people reported to have side effects when taking Soliris.
Among them, 120 people (0.2%) have Cataract.
Among these 120 people:
How long have people been on Soliris when they have Cataract? *
What is the gender of people who have Cataract when taking Soliris? *
What is the age of people who have Cataract when taking Soliris? *
What are other drugs people take besides Soliris? *
What are other side effects people have besides Cataract? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Soliris and have Cataract?
- Check whether Cataract is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Soliris:
- Soliris (58,821 reports)
Cataract treatments and more:
- Cataract (70,564 reports)
How severe was Cataract and when was it recovered:
Expand to all the drugs that have ingredients of eculizumab:
- Cataract and drugs with ingredients of eculizumab (121 reports)
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Soliris:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Cataract:
- Cataract (1,896 drugs)
Browse all the conditions that are associated with Cataract:
- Cataract (2,131 conditions)
Related publications that referenced our studies
- Lin SY, Lin CL, Ju SW, Wang IK, Lin CC, Lin CH, Hsu WH, Liang JA, "Increasing risk of cataract in HCV patients receiving anti-HCV therapy: A nationwide cohort study", PloS one, 2017 Mar .
- Dsouza MC, "Could risperidone have caused the cataract?: A case report and review of literature", Journal of Research in Psychiatry and Behavioral Science, 2015 Jan .
- Dsouza MC, "COULD RISPERIDONE HAVE CAUSED THE CATARACT", JRPBS, 2015 Jan .
- Lin SY, Lin CL, Ju SW, Wang IK, Lin CC, Lin CH, Hsu WH, Liang JA, "Increasing risk of cataract in HCV patients receiving anti-HCV therapy: A nationwide cohort study", PloS one, 2017 Mar .
- Dsouza MC, "Could risperidone have caused the cataract?: A case report and review of literature", Journal of Research in Psychiatry and Behavioral Science, 2015 Jan .
- Dsouza MC, "COULD RISPERIDONE HAVE CAUSED THE CATARACT", JRPBS, 2015 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on eculizumab (the active ingredients of Soliris) and Soliris (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Appetite - Decreased and drugs of ingredients of calcium - 5 seconds ago
- Hepatocellular Carcinoma and Acidosis - 5 seconds ago
- Appetite Decreased and drugs of ingredients of calcium - 5 seconds ago
- Could Cosentyx cause Blood Bilirubin Increased? - 8 seconds ago
- Parnate vs. Sinequan, side effect and effectiveness comparison - 10 seconds ago
- Drug interactions of Propulsid and Novolog - 10 seconds ago
- Could Enbrel cause Motor Neurone Disease? - 12 seconds ago
- Hormone Replacement Therapy and Transient Ischaemic Attack - 21 seconds ago
- Gastroesophageal Reflux Disease in Haldi, how severe and when it was recovered? - 22 seconds ago
- Could Revatio cause Catheter Site Bruise? - 22 seconds ago